fda import alert 66-80 glp-1 api green list Puts Peptide APIs on DWPE Detention Track FDA Launches “Green List” to

Facial/body flushing when first injected Injection site irritation and/or rash Joint and/or muscle pain Fatigue Pain and swelling after repeated shots to the same injection site- (rotate injection site ) In rare cases, some patients have experienced mild hypertension Water retention Warnings and precautions: CJC1295 and Ipamoralin peptides are banned by WADA (world anti-doping agency) for uses in sports CJC1295 may be mitogenic, if patient is prone to cancer and/or have cancer, use with caution CJC1295 may mask symptoms of hypothyroidism, make sure to test thyroid hormone levels (Free and Total T3, T4, TSH and thyroid antibodies) CJC1295 can cause Congestive Heart Failure, Do Not Use if you have a history of cardiac complications CJC1295 is a growth hormone releasing hormone (GHRH) analog= growth hormone mimetic

Correa-Selm LM, Grichnik JM

Patients should be aware of: Dosing Consistency: Without standardized formulations, dosage can vary significantly between sources

Suggested Uses ofL-Glutathione As dietary supplement for adults

(PubMed) Delle Chiaie R, Pancheri P, Scapicchio P